Trial to Evaluate the Efficacy and Safety of HCP1302

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 232 participants.

Also called NCT02587988

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 232 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02587988
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02587988. Randomized; double masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2015-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial to Evaluate the Efficacy and Safety of HCP1302
Condition
Erectile Dysfunction
Condition
Hypertension
Intervention (Drug)
HCP1302
Intervention (Drug)
HGP0904
Intervention (Drug)
Placebo (for HCP1302)
Intervention (Drug)
Placebo (for HGP0904)
Lead sponsor
Hanmi Pharmaceutical Company Limited (class: industry)

Record details

Record id
cardio:ct-nct02587988
Content hash
8e414a46e452c52e3ed78f74a5f3c7d6cba178d9835507a2b90d8625d0fe0f8b